Evaluation of saliva as an alternative sample for SARS-CoV-2 detection

Authors

DOI:

https://doi.org/10.33448/rsd-v13i8.46544

Keywords:

Salivary excretion; Nucleic acid test for COVID-19; SARS-CoV-2 Virus.

Abstract

The objective of this study is to evaluate the efficacy of saliva as an alternative sample for detecting SARS-CoV-2 in healthcare professionals and patients treated at a university hospital in the city of João Pessoa, in the state of Paraíba, by comparing the results with samples collected by nasopharyngeal swab (NPS). The study recruited 365 adult participants who were asymptomatic for COVID-19. Reverse transcription real-time polymerase chain reaction (RT-qPCR) targeting the E gene of SARS-CoV-2 was performed. For statistical analyses, SPSS software was used. The agreement between the two methods was assessed using the Kappa test. Of the 365 samples analyzed, 45 (12.3%) showed detection in at least one type of sample. In NPS and saliva, 21 samples (46.7%) were positive, while 14 samples (31.1%) were positive only for NPS and 10 samples (22.2%) were positive only in saliva. Using NPS samples as the reference gold standard, the sensitivity and specificity of saliva were 60% and 97%, respectively, while the positive and negative predictive values were 68% and 96%, respectively. The accuracy was 93.0%, and the Kappa coefficient was 0.596, indicating moderate agreement. Although the Kappa coefficient indicated moderate agreement in this study, pure saliva samples were similar to those obtained by NPS. The simplicity of collection, the scarcity of PPE, and the transmissibility of the virus favor self-collection of saliva as a more accurate test, leading to a reduction in wait times and faster availability of results.

References

Azzi, L., Maurino, V., Baj, A., Dani, M., d'Aiuto, A., Fasano, M., Lualdi, M., Sessa, F., & Alberio, T. (2021). Diagnostic Salivary Tests for SARS-CoV-2. J Dent Res, 100(2), 115-123.

Güçlü, E., Koroglu, M., Yürümez, Y., Toptan, H., Kose, E., Güneysu, F., & Karabay, O. (2020). Comparison of saliva and oro-nasopharyngeal swab sample in the molecular diagnosis of COVID-19. Rev Assoc Med Bras, 66(8), 1116-1121.

Hanege, F. M., Kocoglu, E., Kalcioglu, M. T., Celik, S., Cag, Y., Esen, F., Bayindir, E., Pence, S., Mese, E. A., & Agalar, C. (2021). SARS-CoV-2 Presence in the Saliva, Tears, and Cerumen of COVID-19 Patients. Laryngoscope, 131(5), 1677-1682.

Jamal, A. J., Mozafarihashjin, M., Coomes, E., Powis, J., Li, A. X., Paterson, A., Anceva-Sam, S., Barat, S., Crowl, G., Faheem, A., Farooqi, L., Khan, S., Prost, K., Poutanen, S., Taylor, M., Yip, L., Zhong, X. Z., McGeer, A. J., & Mubareka, S. (2021). Sensitivity of Nasopharyngeal Swabs and Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2. Clin Infect Dis, 72(6), 1064-1066.

Justo, A. F. O., Bueno, M. S., Barbosa, G. R., Perosa, A. H., Carvalho, J. M. A., Bellei, N. (2021). Comparison of viral load between saliva and nasopharyngeal swabs for SARS-CoV2: the role of days of symptoms onset on diagnosis. Mem Inst Oswaldo Cruz, 116(e210018), 1-4.

Merchán-Hamann, E. & Tauil, P. L. (2021). Proposta de classificação dos diferentes tipos de estudos epidemiológicos descritivos. Epidemiol. Serv. Saude, 30

(1), 1-13.

Rao, M., Rashid, F. A., Sabri, F. S. A. H., Jamil, N. N., Zain, R., Hashim, R., Amran, F., Kok, H. T., Samad, M. A. A., & Ahmad, N. (2021). Comparing Nasopharyngeal Swab and Early Morning Saliva for the Identification of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis, 72(9), 352-356.

Sahajpa, N. S., Mondal, A. K., Ananth, S., Njau, A., Ahluwalia, P., Kota, V., Caspary, K., Ross, T. M., Farrell, M., Shannon, M. P., Fulzele, S., Chaubey, A., Hegde, M., Rojiani, A. M., & Kolhe, R. (2021). Clinical Validation of a Sensitive Test for Saliva Collected in Healthcare and Community Settings with Pooling Utility for Severe Acute Respiratory Syndrome Coronavirus 2 Mass Surveillance. The Journal of Molecular Diagnostics, 23(7), 788-795.

Senok, A., Alsuwaidi, H., Atrah, Y., Ayedi, O. A., Zahid, J. A., Han, A., Marzooqi, A. A., Heialy, S. A., Altrabulsi, B., AbdelWareth, L., Idaghdour, Y., Ali, R., Loney, T., & Alsheikh-Ali, A. (2020). Saliva as an Alternative Specimen for molecular COVID-19 Testing in Community Settings and Population-Based Screening. Infection and Drug Resistance, 13(1), 3393–3399.

Soto, G. P. (2020). Bases Genéticas y Moleculares del COVID-19 (SARS-CoV-2). Mecanismos de Patogénesis y de Respuesta Inmune. Int. J. Odontostomat, 14 (3), 331-337.

Teles, S. G. S., Castro, M. C. S. R., Dutra, S. N., & Santos, L. M. S. (2020). A saliva como alternativa para diagnóstico de Covid-19: uma revisão sistemática. Revista Cienfica da FMC, 15(2), 51-55.

To, K. K. W., Tsang, O. T. Y., Yip, C. C. Y., Chan, K. H., Wu, T. C., Chan, J. M. C., Leung, W. L., Chik, T. S. H., Choi, C. Y. C., Kandamby, D. H., Lung, D. C., Tam, A. R., Poon, R. W. S., Fung, A. Y. F., Hung, I. F. N., Cheng, V. C. C., Chan, J. F. W., & Yuen, K. Y. (2020). Consistent Detection of 2019 Novel Coronavirus in Saliva. Clin Infect Dis, 71(15), 841-843.

Vaz, S. N., Santana, D. S., Netto, E. M., Pedroso, C., Wang, W. K., Santos, F. D. A., & Brites, C. (2020). Saliva is a reliable, non-invasive specimen for SARS-CoV-2 detection. Braz J Infect Dis, 24(5), 422–427.

Wyllie, A. L., Fournier, F., Massana, A. C., Campbell, M., Tokuyama, M., Vijayakumar, P., Warren, J. L., Geng, B., Muenker, C. M., Moore, A. J., Vogels, C. B. F., Petrone, M. E., Ott, I. M., Lu, P., Venkataraman, A., Lu Culligan, A., Klein, J., & Earnest, R. (2020). Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2. N Engl J Med, 383(13), 1283-1286.

Yoon, J. G., Yoon, J., Song, J. Y., Yoon, S. Y., Lim, C. S., Seong, H., Noh, J. Y., Cheong, H. J., & Kim, W. J. (2020). Clinical Significance of a High SARS-CoV-2 Viral Load in the Saliva. J Korean Med Sci, 35(20), 1-6.

Downloads

Published

16/08/2024

How to Cite

BEZERRA, F. G. .; BEZERRA, J. F. .; VASCONCELOS, R. H. T. .; DULGHEROFF, A. C. B. .; SARMENTO, R. R. .; SANTOS, B. M. P. dos .; ADRIANO, M. S. P. F. Evaluation of saliva as an alternative sample for SARS-CoV-2 detection. Research, Society and Development, [S. l.], v. 13, n. 8, p. e6113846544, 2024. DOI: 10.33448/rsd-v13i8.46544. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/46544. Acesso em: 5 jan. 2025.

Issue

Vol. 13 No. 8

Section

Health Sciences

License

Copyright (c) 2024 Felipe Gonçalves Bezerra; João Felipe Bezerra; Romero Henrique Teixeira Vasconcelos; Ana Carolina Bernades Dulgheroff; Ronaldo Rodrigues Sarmento; Betânia Maria Pereira dos Santos; Maria Soraya Pereira Franco Adriano

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.